Altium Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Altium Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$1.13M	Buy
2022 Q1	–	Sell
2021 Q4	$3.78M	Sell
2021 Q3	$5.69M	Buy
2021 Q2	$5.87M	Buy
2021 Q1	$948K	Buy